Study of infection and body chemicals in dialysis patients with sepsis
Part of Infections clinical trials.
This study looks at germs and body chemicals in dialysis patients who are in the hospital with sepsis. The goal is to learn more about how these factors affect recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are on hemodialysis (a type of dialysis using a machine).
- You are currently in the hospital with sepsis (a serious infection affecting the whole body).
- You are able to give written permission (informed consent) to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
This study looks at how sepsis (a severe infection) affects the immune system. The goal is to see if certain blood markers can help doctors predict recovery, which could improve the care of future patients with septic shock.
This study uses special blood testing to learn what is happening in the immune system during sepsis in children and how it may relate to organ injury. Your results may help doctors recognize and treat sepsis earlier and more accurately.
This study looks at how labs process blood cultures for sepsis to find faster, better ways to detect infections. It may help improve treatment speed for patients with sepsis.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This study is testing a blood test that may help doctors diagnose sepsis faster. It involves people with sepsis and healthy volunteers to compare results.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.